Last $139.49 USD
Change Today +0.23 / 0.17%
Volume 555.6K
BCR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

cr bard inc (BCR) Snapshot

Open
$138.89
Previous Close
$139.26
Day High
$140.60
Day Low
$138.51
52 Week High
04/1/14 - $150.13
52 Week Low
04/24/13 - $97.90
Market Cap
10.8B
Average Volume 10 Days
1.1M
EPS TTM
$5.49
Shares Outstanding
77.6M
EX-Date
04/24/14
P/E TM
25.4x
Dividend
$0.84
Dividend Yield
0.59%
Current Stock Chart for CR BARD INC (BCR)

cr bard inc (BCR) Related Businessweek News

No Related Businessweek News Found

cr bard inc (BCR) Details

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular products, including percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. The company’s urology products include Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; devices for the treatment of pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal; catheter stabilization devices; and products for therapeutic hypothermia. It also provides specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers and other diseases and disorders. In addition, the company offers surgical specialty products, such as implanted grafts and fixation devices for hernia and soft tissue repair products; surgical sealants for intraoperative sealing of air leaks in thoracic surgery; and other products that include irrigation, wound drainage, and original equipment manufacturers’ products. It sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities, as well as through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.

13,000 Employees
Last Reported Date: 02/19/14
Founded in 1907

cr bard inc (BCR) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.1M
President, Chief Operating Officer and Direct...
Total Annual Compensation: $887.0K
Group President
Total Annual Compensation: $660.0K
Group President
Total Annual Compensation: $560.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $540.0K
Compensation as of Fiscal Year 2013.

cr bard inc (BCR) Key Developments

CR Bard Inc. Declares Quarterly Dividend, Payable on May 9, 2014

CR Bard Inc. declared a regular quarterly dividend of 21 cents per share on Bard's common stock. The current indicated annual dividend rate is 84 cents per share. The dividend is payable on May 9, 2014 to shareholders of record at the close of business on April 28, 2014.

CR Bard Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 08:00 AM

CR Bard Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 08:00 AM. Venue: The Westin Grand Central Hotel, New York, New York, United States. Speakers: Timothy M. Ring, Chairman, Chief Executive Officer and Chairman of Executive Committee.

CR Bard Inc., Annual General Meeting, Apr 16, 2014

CR Bard Inc., Annual General Meeting, Apr 16, 2014., at 10:00 US Eastern Standard Time. Location: Wyndham Hamilton Park Hotel and Conference Center. Agenda: To elect seven director nominees each for a term of one year; to ratify the appointment of KPMG LLP as its independent registered public accounting firm for fiscal year 2014; to approve the 2012 long term incentive plan of C. R. Bard, Inc., as amended and restated; to approve certain provisions of the executive bonus plan of C. R. Bard, Inc.; to approve the compensation of its named executive officers on an advisory basis; to consider and vote upon a shareholder proposal relating to sustainability reporting, if properly presented at the meeting; to consider and vote upon a shareholder proposal relating to separating the Chair and CEO roles, if properly presented at the meeting; and to transact such other business as may properly come before the meeting and any adjournments thereof.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCR:US $139.49 USD +0.23

BCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $38.50 USD +0.15
Endo International PLC $57.26 USD -0.44
Sigma-Aldrich Corp $94.07 USD +0.05
Varian Medical Systems Inc $80.28 USD -0.61
View Industry Companies
 

Industry Analysis

BCR

Industry Average

Valuation BCR Industry Range
Price/Earnings 16.6x
Price/Sales 3.6x
Price/Book 5.2x
Price/Cash Flow 15.7x
TEV/Sales 2.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CR BARD INC, please visit www.crbard.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.